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UNIT 6.1Probing RNA Structure with Chemical
Reagents and Enzymes
The function of an RNA molecule in vivo and in vitro will often depend on its tertiary
structure as well as the information encoded in its Watson-Crick base-pairing potential.
There are now a number of powerful methods that can be used simultaneously to
determine structural properties of small and large RNAs. This unit and subsequent units
provide methods for RNA footprinting, detecting positions sensitive to chemical and
enzymatic attack in the presence or absence of bound proteins. RNA footprinting differs
profoundly from DNA footprinting in that the starting structure of the RNA cannot be
taken for granted even in general terms, and the footprinting reactions are often carried
out with structure-sensitive reagents precisely for the purpose of elucidating the RNA
solution structure. When interpreting these structures, however, it is necessary to always
consider whether the functional form of the RNA molecule is being examined.
The first four protocols in this unit provide methods for modifying and cleaving RNA for
the purpose of probing structure. Three of these protocols use structure-sensitive chemi-
cals—dimethyl sulfate (DMS; see Basic Protocol 1), diethylpyrocarbonate (DEPC; see
Alternate Protocol 1), and ethylnitrosourea (ENU; see Alternate Protocol 2). The fourth
describes the use of various nucleases (see Table 6.1.1) to probe RNA structure (see Basic
Protocol 2). Three other protocols can be used together to analyze the base-pairing status
of RNA. The reagents modify Watson-Crick positions of nucleotides not involved in base
pairing or tertiary hydrogen bonding. Dimethyl sulfate (see Basic Protocol 3) is used to
probe unpaired adenines and cytidines, while kethoxal (see Alternate Protocol 3) and
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate (CMCT;
see Alternate Protocol 4) are used to investigate unpaired guanosines and uridines,
respectively. RNA cleavages and base modifications can be detected by primer extension
(see Support Protocol 4), or cleavage sites can be detected by using RNA that has been
labeled at the 5′ terminus with T4 polynucleotide kinase (see Support Protocol 1) or the
3′ terminus by T4 RNA ligase (see Support Protocol 2). Support Protocol 3 details the
preparation of electrophoresis standards for use with end-labeled RNA.
CAUTION: When working with radioactivity, take appropriate precautions to avoid
contamination of the experimenter and the surroundings. Carry out the experiment and
dispose of wastes in an appropriately designated area, following the guidelines provided
by the local radiation safety officer.
NOTE: Experiments involving RNA require careful precautions to prevent contamination
and RNA degradation (see APPENDIX 2A).
STRATEGIC PLANNING
Footprinting with an Appropriate RNA
Before undertaking these often labor-intensive footprinting experiments it is worthwhile
to evaluate the extent to which all or most of the RNA sample to be examined is in an
appropriate folded state (see Critical Parameters; for general guidelines for RNA folding,
see UNIT 6.3). There are a number of ways of determining this when the RNA is to be probed
in vitro; the method used depends on which experimental system is available to assess
the structure of the RNA. In the simplest case, the RNA might have an assayable function
that can be demonstrated in vitro. An example of this is an artificial RNA ligand selected
for binding to a protein target in vitro. RNAs isolated from cells are generally more
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difficult to interpret. If an RNA is stripped of its native protein structure in the process of
being isolated from cells, or if an RNA is made synthetically, it should be assumed that
the folding of that RNA is suspect until proven otherwise. Small RNAs that are tightly
structured, such as tRNAs, can often refold in functional form, but this cannot be assumed.
The chances of misfolding increase dramatically for larger RNAs where there are more
potential isoforms. An RNA that is isolated as part of a ribonucleoprotein (RNP) complex,
such as a ribosomal subunit, is generally assumed to be correctly folded, but even that
assumption should be viewed with caution.
Choice of Structure-Sensitive Reagents
The object in RNA footprinting is to determine which positions in the RNA are accessible
to specific types of attack by chemical reagents or nucleases. Cleavage or modification
by these reagents is normally performed under conditions where the target RNA is cleaved
at most once per molecule, thus lowering the chance that the first cleavage/modification
causes an RNA rearrangement that alters access for a second attack. The cleavage or
modification specificities of individual nucleases and commonly used chemicals are listed
in Table 6.1.1. It is worth considering the general advantages and disadvantages of
different classes of reagents. Nucleases have the lowest resolution because their steric
radii do not allow access to many sites that are solvated; however, they are easily used in
a wide range of physiological buffers. Most of the nucleases described below are specific
Table 6.1.1 RNA Structure-Probing Reagents and Their Specificities
Reagenta   Targetb Where discussed Supplier
For cleavage:
DMSc ss or ds G (N7) Basic Protocol 1 Aldrich
DEPCc ss or ds A (N7) Alternate
Protocol 1
Sigma
ENUc Phosphate oxygens Alternate
Protocol 2
Sigma
Hydroxyl radicals Ribose sugar backbone UNIT 6.5
Pb2+ Phosphates of ss
nucleotides
UNIT 6.3
Mung bean nucleased ss N/pN Basic Protocol 2 Roche or Promega
RNase A ss Cp/N and Up/N Basic Protocol 2 Roche
RNase CL3 ss Cp/N Basic Protocol 2 USB
RNase I(ONE) ss Np/N Basic Protocol 2 Promega (RNase ONE)
RNase Phy M ss Ap/N and Up/N Basic Protocol 2 Pharmacia
RNase T1 ss Gp/N Basic Protocol 2 Life Technologies
RNase T2 ss Np/N Basic Protocol 2 Life Technologies
RNase U2 ss Ap/N Basic Protocol 2 Pharmacia
RNase V1d ds N/pN Basic Protocol 2 Pharmacia
S1 nucleased ss N/pN Basic Protocol 2 Roche or Promega
For modification:
CMCT Primarily U (N3) and
possibly G (N1)
Alternate Protocol 4 Aldrich
DMS A (N1) and C (N3) Basic Protocol 3 Aldrich
Kethoxal G (N1, 2-NH2) Alternate Protocol 3 ICN or Research
Organics
aAbbreviations: CMCT, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate; DEPC, diethylpy-
rocarbonate; DMS, dimethyl sulfate; ds, double-stranded; ENU, ethylnitrosourea; ss, single-stranded.
bCleavage site indicated by shill. Specific position of cleavage or modification are indicated in parentheses.
cThis reagent requires further chemical processing to cleave the RNA.
dNuclease requires divalent cations for activity. For RNase V1, MgCl2 (10 mM final) is recommended, mung bean nuclease
and S1 nuclease require zinc acetate as per supplier’s instructions.
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for nucleotides not involved in Watson-Crick pairing, with variable sensitivity to other
types of structure and base specificity. The exception is cobra venom ribonuclease (V1),
which is the only reagent described here that is specific for double-stranded regions. Even
V1 is not exceptionally helpful in identifying double-stranded structures, however,
because the ability of V1 to cleave helices is variable. Cleavage by V1 is infrequent, and
V1 can cleave adjacent to rather than within helices.
The available chemical reagents discussed in this and subsequent units allow better access
to all regions of the RNA tertiary structure and cumulatively attack a wide range of
nucleotide positions. In general, using a larger number of different reagents to probe
allows a more detailed view of solvent-exposed positions. Exposure of phosphates, sugars,
and aromatic ring positions can be probed. Reagents specific for Watson-Crick positions
are often used as diagnostics for the existence of standard base pairing at contiguous
nucleotides. Some of the protocols described below are based on methods described
previously (Peattie and Gilbert, 1980; Knapp, 1989; Krol and Carbon, 1989).
Location of chemical and nuclease cleavages can be determined using end-labeled RNA
or primer extension. Hydroxyl radicals (UNIT 6.5) and Pb2+ (UNIT 6.3) will directly hydrolyze
the phosphodiester backbone, as will the various nucleases according to their sequence
and structural preferences. Other reagents, including DMS, DEPC, and ENU, require
additional chemical steps, ultimately resulting in strand scission.
Detection of Modifications or Cleavage Sites
The method used to detect cleavages or modified positions varies with both the nature of
the RNA being probed and the reagents being used. Short RNAs (<200 nucleotides) can
be labeled at either the 5′ or 3′ end (Support Protocols 1 and 2), then folded and subjected
to reagents that result in RNA strand cleavage. Separation of the cleaved RNA on
denaturing polyacrylamide gels and determination of fragment sizes identifies the posi-
tion of cleavage sites. Alternatively, a labeled DNA oligomer primer can be annealed at
any point along the length of an unlabeled RNA and extended to a point of cleavage or
Watson-Crick base modification (Support Protocol 4). Either case terminates extension
and produces a labeled DNA fragment corresponding to the length from the label to the
termination site. There are a variety of labels that can be used with these two general
detection schemes. The most common label is 32P, which can be detected with either X-ray
film or a phosphorimager.
The question of whether to use end labeling or primer extension for detection depends on
the RNA to be analyzed and how many reagents are needed. Primer extension is more
often useful for longer RNAs, although end labeling is still widely used to probe small
RNAs. The advantage of end labeling is that it requires fewer manipulations (i.e., no
primer-extension reactions) after the cleavage reactions. Its disadvantages include that it
can only be used for relatively short RNAs that can be labeled before cleavage reagent
treatment and that it requires cleavage of the RNA strand for detection. Transfer RNAs,
5S rRNAs, and other small, structured RNAs have typically been investigated by end
labeling.
Primer extension has four main disadvantages. The first is that the extreme 3′ end of the
RNA cannot be probed because the primer must anneal to the 3′ side of the region to be
extended across. The second disadvantage is that sequence-dependent pausing and
termination by the reverse transcriptase, even on intact RNA, tends to give a high
background at some positions that obscures the true signal from cleavage or modification.
This problem can be reduced by using different reverse transcriptases and/or extension
conditions, but is never completely eliminated with structured RNAs. The third disadvan-
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tage is that additional manipulations are required to perform the primer-extension reac-
tions following the cleavage or modification reactions. Finally, cellular RNAs may contain
posttranscriptional modifications that will terminate the extension reaction. However,
primer-extension RNA footprinting is potentially useful in many situations. For example,
RNA of any size can be probed because a labeled primer can be placed anywhere along
the length of RNA, and multiple primers can be used in separate reactions to detect
cleavages or modifications along the entire length. The RNA also does not need to be
purified or labeled in advance, allowing probing of preformed RNA-protein complexes
even in crude cell lysates. Following the cleavage/modification reactions, protein is
removed by organic extraction and the purified RNA is subjected to primer extension.
Lastly, the extension reactions can be used to detect several chemical modifications at
Watson-Crick positions in addition to any form of RNA strand cleavage.
BASIC
PROTOCOL 1
MODIFICATION AND CLEAVAGE OF RNA USING DIMETHYL SULFATE
Dimethyl sulfate (DMS) alkylates the N7 cyclic amine of guanosine. The methylated
nucleoside is reduced, opening the imidizole ring and weakening the glycosidic bond.
Aniline treatment catalyzes the β-elimination of the ribose sugar, leaving the nucleotide
5′ of the displaced guanosine with a 3′ phosphate and the nucleotide 3′ of the guanosine
with a 5′ phosphate. The N7 position is pointed into the major groove of an A-form RNA
helix and is accessible to modification. Therefore, the N7 of double-stranded and
single-stranded guanosines should be detected unless participating in tertiary structure or
non-Watson-Crick base-pair interactions. See Strategic Planning for a discussion of
choice of RNA, folding, and detection methods.
Materials
1 M HEPES, pH 7.8
1 M KCl
0.1 M MgCl2
1 µg/µL carrier RNA (see recipe)
Sample RNA, end labeled (see Support Protocol 1 or Support Protocol 2) or
unlabeled
RNase-free water (see recipe)
≥99% dimethyl sulfate (DMS) (Aldrich)
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
100% and 70% (v/v) ethanol
1 M Tris⋅Cl, pH 8.0 (APPENDIX 2A)
0.2 M NaBH4, prepared fresh
1 M aniline acetate buffer (see recipe)
FEXS solution (see recipe; for end-labeled RNA)
Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (e.g., APPENDIX 3B or CPMB UNIT 2.12) or primer extension (see
Support Protocol 4)
NOTE: DMS is highly toxic and a suspected carcinogen; use appropriate precautions for
handling, storage, and disposal.
Methylate guanosine N7
1. Prepare reaction mix as follows:
8 µL 1 M HEPES, pH 7.8 (final 200 mM)
4 µL 1 M KCl (100 mM)
4 µL 0.1 M MgCl2 (10 mM)
8 µL 1 µg/µL carrier RNA (0.2 µg/µL).
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2. Combine 50,000 cpm end-labeled sample RNA or 0.5 µg unlabeled sample RNA (for
primer extension) with RNase-free water to make 15 µL total and add to reaction
mix.
3. Add 1 µL of 99+% DMS, mix, and incubate 2 min at room temperature. 
4. Stop the reaction by precipitating with 4 µL of 3 M sodium acetate and 120 µL of
100% ethanol on dry ice. Microcentrifuge 30 min at maximum speed (10,000 rpm),
4°C. Remove supernatant, rinse with 70% ethanol, and dry the pellet in a speedvac.
Reduce methylated RNA and perform aniline cleavage
5. Resuspend pellet with 20 µL of 1 M Tris⋅Cl and 20 µL of 0.2 M NaBH4.
6. Incubate 30 min on ice in the dark.
7. Precipitate as in step 4.
8. Resuspend pellet in 40 µL of 1 M aniline acetate buffer and incubate 15 min in the
dark at 60°C.
9. Precipitate as in step 4.
10. If end-labeled RNA was used, resuspend in 12 µL FEXS solution and proceed with
direct gel electrophoresis (e.g., APPENDIX 3B). If RNA sample was unlabeled, see
Support Protocol 4 and perform primer extension.
See Support Protocol 3 for preparation of appropriate end-labeled RNA standards for
electrophoresis.
ALTERNATE
PROTOCOL 1
MODIFICATION AND CLEAVAGE OF RNA USING
DIETHYLPYROCARBONATE
Diethylpyrocarbonate (DEPC) alkylates the N7 cyclic amine of adenosine. The mecha-
nism and procedure are essentially identical to those described for DMS (see Basic
Protocol 1), except that DEPC is used and the incubation time is increased (replace step
3 in Basic Protocol 1 with the following step). See Strategic Planning for discussions of
choice of RNA, folding, and detection methods.
Additional Materials (also see Basic Protocol 1)
≥97% diethylpyrocarbonate (DEPC) (store up to 1 year at 2° to 8°C)
NOTE: DEPC is toxic. Handle with appropriate care. 
3b. Add 1 µL DEPC, mix, and incubate 45 min at room temperature. 
ALTERNATE
PROTOCOL 2
MODIFICATION AND CLEAVAGE OF RNA USING ETHYLNITROSOUREA
Ethylnitrosourea (ENU) alkylates phosphate oxygens that are not involved in tertiary
structure interactions. These include phosphates of both single-stranded and double-
stranded nucleotides not participating in higher-ordered structure. Following alkaline
treatment, the phosphotriester hydrolyzes resulting in RNA strand scission. See Strategic
Planning for discussions of choice of RNA, folding, and detection methods.
Additional Materials (also see Basic Protocol 1)
ENU/ethanol solution (see recipe)
0.1 M Tris⋅Cl, pH 9.0 (APPENDIX 2A)
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Alkylate phosphates
1. Prepare reaction mix as follows:
2 µL 1 M HEPES, pH 7.8 (final 200 mM)
1 µL 1 M KCl (100 mM)
1 µL 0.1 M MgCl2 (10 mM)
2 µL 1 µg/µL carrier RNA (0.2 µg/µL)
2. Combine 50,000 cpm end-labeled sample RNA or 0.5 µg unlabeled sample RNA (for
primer extension) with RNase-free water to make 3 µL total and add to reaction mix.
3. Add 1 µL of ENU/ethanol solution, mix, and incubate 30 min at room temperature. 
4. Stop the reaction by precipitating with 1 µL of 3 M sodium acetate and 30 µL of
100% ethanol on dry ice. Microcentrifuge 30 min at maximum speed (10,000 rpm),
4°C. Remove supernatant, rinse with 70% ethanol, and dry the pellet in a speedvac.
Hydrolyze phosphotriesters
5. Resuspend pellet in 10 µL of 0.1 M Tris⋅Cl, pH 9.0, and incubate 5 min at 50°C.
6. Precipitate as in step 4.
7. If RNA has been end-labeled, resuspend in 12 µL FEXS solution and proceed with
gel electrophoresis (e.g., APPENDIX 3B or CPMB UNIT 2.12). If RNA sample was not labeled,
perform primer extension (see Support Protocol 4). 
See Support Protocol 3 for preparation of appropriate end-labeled RNA standards for
electrophoresis.
BASIC
PROTOCOL 2
CLEAVAGE OF RNA USING NUCLEASES
Nucleases hydrolyze the RNA phosphodiester backbone resulting in strand scission.
Cleavages can be identified using primer extension (see Support Protocol 4) or end-la-
beled RNA (see Support Protocol 1 and Support Protocol 2). Table 6.1.1 lists nuclease
specificities and cleavage locations. Some nucleases use divalent metal cofactors to
catalyze the reaction. Divalent-independent nucleases can be used to probe RNA in the
presence and absence of divalent-dependent tertiary structures. Most nucleases are
specific for single-stranded bases and require access to the base determinants for cleavage
site recognition. Uncleaved nucleotide targets may be obscured from cleavage by tertiary
structure or local steric hindrance.
Being relatively large, nucleases may not penetrate some RNA structures completely, and
it is common for some potential targets to remain uncleaved. The data obtained from one
nuclease will identify general structural trends (e.g., single- or double-stranded character),
but often needs to be corroborated using additional nucleases or chemical probes. See
Strategic Planning for discussions of choice of RNA, folding, and detection methods.
Materials
One of the following nucleases (see Table 6.1.1):
 Mung bean nuclease
 RNase A
 RNase CL3
 RNase I(ONE)
 RNase Phy M
 RNase T1
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 RNase T2
 RNase U2
 RNase V1
 S1 nuclease
0.1 M Tris⋅Cl, pH 7.5 (APPENDIX 2A)
1 M KCl (APPENDIX 2A)
0.1 M MgCl2
1 µg/µL carrier RNA (see recipe)
Sample RNA, end labeled (see Support Protocol 1 or Support Protocol 2) or
unlabeled
RNase-free water (see recipe)
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
100% and 70% (v/v) ethanol
FEXS solution (see recipe)
Additional reagents and equipment for direct gel electrophoresis (e.g., APPENDIX 3B
or CPMB UNIT 2.12) or primer extension (see Support Protocol 4)
1. Prepare six reaction tubes, each containing:
1 µL 0.1 M Tris⋅Cl, pH 7.5 (final 10 mM)
1 µL 1 M KCl (100 mM)
1 µL 0.1 M MgCl2 (10 mM)
2 µL 1 µg/µL carrier RNA (0.2 µg/µL).
2. For each reaction mix, combine 50,000 cpm end-labeled sample RNA or 0.5 µg
unlabeled sample RNA (for primer extension) with RNase-free water to make 4 µL
total. Add to each reaction mix.
3. Dilute nuclease at six 5-fold serial dilutions (covering four orders of magnitude) with
10 mM Tris⋅Cl to give the appropriate amounts in a volume of 1 µL. Dilute RNase
V1 with 10 mM Tris⋅Cl and 10 mM MgCl2.
Nuclease activity varies by lot and by manufacturer. Thus, it is necessary to titrate the
amount of nuclease necessary to cleave ∼10% of the RNA of interest. A second titration
consisting of narrower increments may be necessary once the desired activity is found.
Table 6.1.2 lists activity units that have produced 10% cleavage using the reaction
conditions described above. These should be used as guidelines only.
Table 6.1.2 Quantities of Nuclease That Achieve
~10% Cleavage in 10 min
Nuclease Quantitya
Mung bean nuclease ND
RNase A 0.2 ng
RNase CL3 0.025-0.100 U
RNase I(ONE) 0.012 U
RNase Phy M 1.0 U
RNase T1 0.138 U
RNase T2 ND
RNase U2 1.0 U
RNase V1 0.047 U
S1 nuclease ND
aND, not determined
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Fresh nuclease dilutions should be used each time, although dilutions of RNases T1, A, and
I(ONE) can be frozen with minimal loss of activity.
4. Add 1 µL of each nuclease dilution to a reaction mix, mix well, and incubate 10 min
at room temperature.
5. Add 1 µL of 3 M sodium acetate and 30 µL of 100% ethanol and precipitate on dry
ice. Microcentrifuge 30 min at maximum speed (10,000 rpm), 4°C. Remove super-
natant, rinse with 70% ethanol, and dry the pellet in a speedvac.
6. If the RNA sample was end-labeled, resuspend in 12 µL of FEXS solution and
proceed with gel electrophoresis (e.g., APPENDIX 3B or CPMB UNIT 2.12). If sample RNA
was not labeled, see Support Protocol 4 and perform primer extension. 
See Support Protocol 3 for preparation of appropriate end-labeled RNA standards for
electrophoresis.
SUPPORT
PROTOCOL 1
LABELING THE 5′ RNA TERMINUS USING T4 POLYNUCLEOTIDE
KINASE AND [-32P]ATP
Bacteriophage T4 polynucleotide kinase will transfer the γ phosphate of [γ-32P]ATP to an
RNA substrate containing a 5′ hydroxyl group, or it will exchange the radiolabeled γ
phosphate with a single 5′ phosphate present on the RNA substrate. The 5′ end of cellular
RNAs may contain methyl guanosine cap structures that prohibit labeling by this method.
Chemical solid-phase synthesis produces an RNA with a 5′ hydroxyl available for
radiolabeling using [γ-32P]ATP and polynucleotide kinase, whereas RNA transcribed in
vitro has a 5′ triphosphate that must first be removed with a phosphatase. Dephosphory-
lation is accomplished with bacterial alkaline phosphatase and its accompanying buffer.
An alternate method, not described here, of generating 5′-labeled RNA by enzymatic
synthesis is to transcribe in vitro with T7 RNA polymerase and [γ-32P]GTP, incorporating
32P at only the 5′ terminal triphosphate (Milligan and Uhlenbeck, 1989).
This protocol can also be used to produce 5′ end-labeled DNA oligomers to be used as
primers in primer extension (see Support Protocol 4). This is done by performing the
labeling reaction below (steps 8 to 11) with the appropriate DNA oligomer.
Materials
RNA of interest
150 U/µL bacterial alkaline phosphatase (BAP; Life Technologies)
RNase-free water (see recipe)
10× dephosphorylation buffer: 100 mM Tris⋅Cl, pH 8.0 (APPENDIX 2A)
25:24:1 (v/v/v) phenol/chloroform/isoamyl alcohol (APPENDIX 2A)
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
100% and 70% (v/v) ethanol
10 mM EDTA (APPENDIX 2A)
10× kinase buffer (see recipe)
0.1 M dithiothreitol (DTT)
150 µCi/µL [γ-32P]ATP (6000 Ci/mmol; NEN Life Sciences)
10,000 U/mL T4 polynucleotide kinase
Stop mix (see recipe)
Water baths, 37°C and 90° to 100°C
Additional reagents and equipment for phenol/chloroform/isoamyl alcohol
extraction (APPENDIX 2A)
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Dephosphorylate RNA (optional)
1. Calculate picomoles of RNA in 0.2 µg and set up the following reaction mix:
0.2 µg RNA of interest
10 µL of 10× dephosphorylation buffer
RNase-free water to give 100 µL final volume.
70 U BAP per picomole RNA(dilute with 1x dephosphorylation buffer if
necessary)
Phosphate treatment is necessary if the RNA sample was generated by in vitro transcription.
See also supplier’s technical bulletin for recommended reaction conditions.
2. Incubate 1 hr at 65°C.
3. Extract with 100 µL of 25:24:1 phenol/chloroform/isoamyl alcohol to stop the
reaction.
4. Remove the aqueous phase to a new tube. Add 10 µL of 3 M sodium acetate and 300
µL of 100% ethanol. Precipitate on dry ice and then microcentrifuge 30 min at
maximum speed (10,000 rpm), 4°C. Remove supernatant, rinse with 70% ethanol, and
dry the pellet in a speedvac. 
5. Bring 0.2 µg RNA to 18 µL with RNase-free water.
Denature RNA sample (optional)
6. Add 2 µL of 10 mM EDTA. Heat 2 min at 90° to 100°C, then quickly transfer to an
ice water bath and cool 5 min.
Denaturation will increase labeling efficiency of base-paired or recessed 5′ termini;
however, some RNA samples may be labeled more efficiently when folded.
7. Briefly microcentrifuge at maximum speed to collect any condensation.
Label RNA
8. Combine the following and incubate 1 hr at 37°C.
13 µL denatured RNA (0.13 µg)
2 µL 10× kinase buffer
2 µL 0.1 M DTT
2 µL [γ-32P]ATP
1 µL T4 polynucleotide kinase (10 U).
A crude preparation of [γ-32P]ATP is sufficient for this reaction and is less expensive.
To label DNA primers, replace RNA with ~1 g DNA oligomer and proceed through step
11.
9. Add 4 µL stop mix and 100 µL of 100% ethanol (5 vol).
10. Precipitate on dry ice, then microcentrifuge 30 min at maximum speed (10,000 rpm),
4°C.
11. Carefully remove supernatant (very radioactive) and dry the pellet in a speedvac.
If the RNA is not going to be used immediately, resuspend the pellet in the appropriate
buffer or water to reduce radiation-induced damage and freeze at −80°C. The length of
time the RNA can be stored is limited by its activity; the half life of 32P is 14 days.
Current Protocols in Nucleic Acid Chemistry
6.1.9
Chemical and
Enzymatic Probes
for Nucleic Acid
Structure
12. If a heterogeneous population exists, purify the radiolabeled RNA by denaturing gel
electrophoresis (APPENDIX 3B). 
The RNA must have a discrete length to accurately identify nucleotide cleavages/modifi-
cations in the subsequent structure probing experiments.
SUPPORT
PROTOCOL 2
LABELING THE 3′ RNA TERMINUS USING T4 RNA LIGASE AND [32P]pCp
Bacteriophage T4 RNA ligase will catalyze phosphodiester formation between a nucleo-
tide 3′ hydroxyl and a nucleotide 5′ phosphate. The RNA of interest requires a 3′ hydroxyl
that will be coupled to 5′-[32P]cytidine-3′,5′-bisphosphate ([32P]pCp). [32P]pCp can be
purchased or generated using 3′-cytosine-monophosphate, [γ-32P]ATP, and T4 polynu-
cleotide kinase (England et al., 1980; UNIT 6.3). The latter method is recommended because
it generates the concentrated form needed at a reasonable cost.
Enzymatically synthesized RNAs have a 3′ hydroxyl that can be directly ligated with
radiolabeled [32P]pCp. Breakdown of RNA by nucleases, metal or alkaline hydrolysis,
and cleavage by ribozymes (excluding RNase P) produces 2′-3′ cyclic phosphates, which
subsequently hydrolyze to 3′ phosphates and cannot be directly 3′ end labeled. Dephos-
phorylation of 3′ phosphates is accomplished with bacterial alkaline phosphatase and
accompanying buffer (see Support Protocol 1).
Additional Materials (also see Support Protocol 1)
0.5 M HEPES, pH 7.9 at 50 mM
0.1 M MgCl2
0.1 mg/mL bovine serum albumin (BSA)
1 mM ATP
Dimethyl sulfoxide (DMSO)
500 µM 5′-[32P]cytidine-3′,5′-bisphosphate ([32P]pCp; UNIT 6. 3 or Amersham)
20 to 25 U/µL T4 RNA ligase
Dephosphorylate RNA (optional)
1. If necessary, dephosphorylate RNA as described (see Support Protocol 1, steps 1 to
4), but increase RNA to 2 µg and increase BAP accordingly.
2. Resuspend pellet in 10 µL RNase-free water to make 0.2 µg/µL (∼6 µM for a
100-nucleotide RNA).
Label RNA
3. Mix the following (10 µL total volume):
1 µL 10 µM RNA of interest (final 1 µM)
1 µL 0.5 M HEPES, pH 7.9 at 50 mM (50 mM)
2 µL 0.1 M MgCl2 (20 mM)
1 µL 0.1 mg/mL BSA (10 µg/mL)
1 µL 30 mM DTT (3 mM)
1 µL 1 mM ATP (0.1 mM)
1 µL DMSO (10% v/v)
1 µL 500 µM [32P]pCp (50 µM)
1 µL 20 to 25 U/µL T4 RNA ligase (2 to 2.5 U/ µL)
4. Incubate ≥12 hr at 4°C (typically overnight).
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5. Add 90 µL RNase-free water, mix, and extract with 100 µL of 25:24:1 phenol/chlo-
roform/isoamyl alcohol.
6. Add 10 µL of 3 M sodium acetate and 300 µL of 100% ethanol.
7. Precipitate and purify as described (see Support Protocol 1, steps 10 to 12).
SUPPORT
PROTOCOL 3
PREPARING STANDARDS FOR ELECTROPHORESIS OF END-LABELED
RNA CLEAVAGE PRODUCTS
Limited alkaline hydrolysis and digestion with RNase T1 under denaturing conditions
are used to prepare two separate sets of electrophoresis standards in order to determine
sites of end-labeled RNA cleavage. Alkaline hydrolysis results in a relatively even ladder
of truncated RNAs. A denaturing RNase T1 digest cleaves the RNA 3′ of each guanosine.
Comparison of the two products with the modified/cleaved end-labeled RNA after
electrophoresis identifies guanosines along the alkaline hydrolysis ladder, and therefore
the intervening products present in the alkaline hydrolysis reaction can be determined
from the RNA sequence. End-labeled RNA cleavage products from structure-probing
reactions can thus be identified.
Materials
RNA of interest, 32P-end-labeled to 50,000 cpm (see Support Protocol 1 or
Support Protocol 2)
100% (v/v) ethanol
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
Na2CO3/EDTA solution (see recipe)
CU buffer (see recipe)
RNase T1 (Life Technologies)
2 µg/µL tRNA carrier (see recipe for carrier RNA)
CEU buffer (see recipe)
FEXS solution (see recipe)
95°C water bath
Alkaline Hydrolysis of RNA
1. Ethanol precipitate 50,000 cpm of end-labeled RNA in 1/10 vol of 3M sodium acetate,
pH 5.2 and 3 vol of 100% ethanol, microcentrifuge 30 min at maximum speed, 4°C
(10,000 rpm), and dry the pellet in a speedvac.
2. Resuspend with 1.2 µL Na2CO3/EDTA solution and mix with a pipet.
3. Incubate between 90 and 120 sec at 95°C, then 1 min on ice.
Initially, vary incubation time at 95°C to achieve a relatively even ladder of products
following electrophoresis, thereafter use the most successful incubation time.
4. Add 2.8 µL of CU buffer and mix to neutralize.
5. Add 8 µL FEXS solution. Store frozen at −80°C, if necessary.
The time the RNA can be stored is dependent on the signal detection and the 32P half life
(14 days).
RNase T1 Digest of RNA
6. Add 5 µL of 2 µg/µL carrier tRNA to a second aliquot of 50,000 cpm end-labeled
RNA. Ethanol precipitate with 1/10th vol 3 M sodium acetate, and 3 vol 100%
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ethanol, microcentrifuge 30 min at maximum speed (10,000 rpm), 4°C, and dry the
pellet in a speedvac.
7. Resuspend with 3 µL CEU buffer and mix with a pipet.
8. Incubate 5 min at 50°C.
9. Add 1 µL RNase T1 diluted in CEU buffer and incubate 15 min at 50°C. 
The appropriate RNase T1 dilution will need to be determined by titration, but 1 to 3 U
typically produces good results.
Alternatively, other urea-tolerant nucleases, such as RNase A (C and U specific), can be
used.
10. Add 8 µL FEXS solution. Store frozen at −80°C, if necessary.
BASIC
PROTOCOL 3
MODIFICATION OF RNA AT WATSON-CRICK POSITIONS USING
DIMETHYL SULFATE
Watson-Crick positions of adenosines (N1) and cytidines (N3) not involved in base pairing
or tertiary-structure hydrogen bonding are alkylated by DMS. Primer extension (see
Support Protocol 4) of modified RNA and comparison with dideoxynucleotide sequenc-
ing reactions identifies the modified bases. Used together, dimethyl sulfate (for A and C),
kethoxal (for G; see Alternate Protocol 3), and CMCT (for U; see Alternate Protocol 4)
provide a complete analysis of the base-pairing status (i.e., secondary structure) of the
RNA of interest. See Strategic Planning for discussions of RNA sample source and
folding.
Materials
0.5 M HEPES, pH 7.8
1 M KCl (APPENDIX 2A)
0.1 M MgCl2
1 µg/µl RNA of interest
RNase-free water (see recipe)
10.56 M dimethyl sulfate (DMS; 99+%) 
100% and 70% (v/v) ethanol
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
Additional reagents and equipment for primer extension (see Support Protocol 4)
CAUTION: DMS is highly toxic and a suspected carcinogen; appropriate precautions
should be taken for handling, storage, and disposal.
1. Prepare four reaction tubes, each containing:
1 µL 0.5 M HEPES, pH 7.8 (final 50 mM)
1 µL 1 M KCl (100 mM)
1 µL 0.1 M MgCl2 (10 mM)
2 µL 1 µg/µL RNA of interest (0.2 µg/µL)
4 µL RNase-free water
2. Just prior to use, dilute DMS in four 2-fold serial dilutions in 100% ethanol to give
the appropriate amounts in a volume of 1 µL.
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DMS must initially be titrated to attain the desired RNA modification typically ~10%. The
following dilutions are provided as examples only. Dilute 1L of 10.56 M DMS stock in
16.6 L of 100% ethanol to give 600 mM. Further dilute 2-, 4-, and 8-fold with 100%
ethanol to make 300, 150, and 75 mM dilutions, respectively. The final reaction concen-
trations will be 60, 30, 15, and 7.5 mM.
3. Add 1 µL of each DMS dilution to a reaction mix, mix well, and incubate 20 min at
room temperature.
4. Add 1 µL of 3 M sodium acetate and 30 µL of 100% ethanol and precipitate on dry
ice. Microcentrifuge 30 min at maximum speed (10,000 rpm), 4°C. Remove super-
natant, rinse with 70% ethanol, and dry the pellet in a speedvac.
5. Resuspend pellet in 40 µL RNase-free water and proceed with primer extension (see
Support Protocol 4) using 4 µL (0.2 µg) per reaction.
ALTERNATE
PROTOCOL 3
MODIFICATION OF RNA AT WATSON-CRICK POSITIONS USING
KETHOXAL
Kethoxal alkylates the N1 and 2-NH2 Watson-Crick positions of guanosines not involved
in base pairing or tertiary-structure hydrogen bonding. The procedure is the same as for
modification with DMS (see Basic Protocol 3), except that step 2 is replaced with the
following step. Used together, dimethyl sulfate (A & C; Basic Protocol 3), kethoxal (G),
and CMCT (U; Alternate Protocol 4) provide a complete analysis of the base-pairing
status (i.e., secondary structure) of the RNA of interest. See Strategic Planning for
discussion of RNA sample source and folding.
Additional Materials (also see Basic Protocol 3)
4.27 M kethoxal stock (ICN or Research Organics)
2b. Just prior to use, dilute 4.27 M kethoxal in four 2-fold serial dilutions in RNase-free
water to give the appropriate amounts in a volume of 1 µL.
Kethoxal must be titrated to attain the desired RNA modification. The following dilutions
are provided as examples only.
Dilute 1 L of 4.27 M kethoxal stock in 20.35 L water to give 200 mM. Further dilute 2-,
4-, and 8-fold with water to make 100, 50, and 25 mM dilutions, respectively. Final reaction
concentrations will be 20, 10, 5, and 2.5 mM.
ALTERNATE
PROTOCOL 4
MODIFICATION OF RNA AT WATSON-CRICK POSITIONS USING CMCT
1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate (CMCT)
alkylates the N3 Watson-Crick position of uridines not involved in base pairing or
tertiary-structure hydrogen bonding. The approach is essentially as described for modi-
fication with DMS (see Basic Protocol 3), except that the reactions are performed as
outlined below. Used together, dimethyl sulfate (A & C; Basic Protocol 3), kethoxal (G;
Alternate Protocol 3), and CMCT (U) provide a complete analysis of the base-pairing
status (i.e., secondary structure) of the RNA of interest. See Strategic Planning for
discussion of RNA sample source and folding.
Additional Materials (also see Basic Protocol 3)
0.5 M potassium borate, pH 8.0
0.5 M 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate
(CMCT) in RNase-free H2O (stable for several weeks at –20°C; Aldrich)
37°C water bath
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1. Prepare three reaction tubes, each containing:
1 µL 0.5 M potassium borate, pH 8.0 (final 50 mM)
1 µL 1 M KCl (100 mM)
1 µL 0.1 M MgCl2 (10 mM)
2 µL 1 µg/µL RNA of interest (0.2 µg/µL)
2. Just prior to use, heat 0.5 M CMCT at 37°C and vortex to ensure the reagent is
completely solubilized. Immediately dilute 0.5 M CMCT solution to 200 mM and 50
mM in RNase-free water.
CMCT must be titrated to attain the desired RNA modification. The above dilutions can be
used for the initial titration. Final reaction concentrations using the stock solution and the
two dilutions will be 250, 100, and 25 mM, respectively.
3. Add 5 µL of each CMCT dilution to a reaction mix, mix well, and incubate 20 min
at room temperature.
4. Precipitate and proceed to primer extension as described (see Basic Protocol 3, steps
4 and 5).
SUPPORT
PROTOCOL 4
DETECTION OF RNA CLEAVAGE OR MODIFICATION BY PRIMER
EXTENSION
Primer extension of a radiolabeled DNA oligomer will synthesize a complementary DNA
strand to the RNA of interest. Reverse transcriptase will stop upon encountering alkylated
Watson-Crick determinants, resulting in a product one base short of the modification. The
enzyme will also run off RNA cleavage products, producing a DNA corresponding to the
site of cleavage. Strong secondary structure, such as hairpin loops within the RNA, can
cause the enzyme to pause, creating a prematurely terminated product. It is therefore
essential to perform the reaction on unmodified/uncleaved RNA as a control. This enables
pause sites from secondary structure to be subtracted from the modification/cleavage
analysis. Because carrier RNA can affect the reverse transcription reaction, control
reactions should include the carrier RNA as well. The reaction requires a DNA oligomer
complementary to the RNA of interest, 3′ of the region to be examined. It might be
necessary to use several DNA oligomers to examine an RNA several hundred nucleotides
long. The extension products are resolved on standard DNA sequencing gels, allowing
∼200 nucleotides to be examined per DNA primer. Location of primer-extension termi-
nations is determined by comparison to standard dideoxynucleotide sequencing reactions
using the same primer and a template of the same sequence as the RNA being examined.
The primer-extension reaction requires a 32P-labeled DNA oligomer that is generated
using bacteriophage T4 polynucleotide kinase. Reaction conditions for labeling the
primer are identical to those used for end labeling the 5′ RNA terminus (see Support
Protocol 1), but substituting the DNA oligomer for the RNA.
Materials
[5′-32P]DNA oligomer (see Support Protocol 1) complementary to 3′ end of the
sample RNA
Sample RNA, cleaved or modified (see Basic Protocols 1 to 3 and Alternate
Protocols 1 to 4)
RNase-free water (see recipe)
Sample RNA, uncleaved and unmodified
25 mM 4dNTP mix (see dNTPs in APPENDIX 2A)
0.1 M dithiothreitol (DTT)
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5× first strand buffer (see recipe)
200 U/µL Superscript II RNase H(−) Moloney murine leukemia virus reverse
transcriptase (MMLV RT; Life Technologies; see Troubleshooting for
alternative RTs)
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
100% and 70% (v/v) ethanol
FENXB solution (see recipe)
Dideoxynucleotide sequencing reactions (e.g., CPMB UNIT 7.4A) of cDNA for sample
RNA
Sequencing gel: 6% (w/v) acrylamide (20:1 mono-/bis-), 8 M urea, 1× TBE buffer
(APPENDIX 2A for TBE buffer)
Water bath or heating block, 42° and 70°C
Additional reagents and equipment for running a sequencing gel (APPENDIX 3B)
Anneal primer
1. Mix the following:
100,000 cpm [5′-32P]DNA oligomer
0.2 µg sample RNA, cleaved or modified
RNase-free water to 18.5 µL.
It may be necessary to titrate the [32P]DNA oligomer and RNA concentrations to optimize
the extension reaction conditions.
2. Set up a similar control reaction using unmodified, uncleaved RNA.
This control should be performed to identify structure-induced terminations and to ensure
that the majority of the DNA oligomer is being fully extended through the region of interest.
3. Incubate 10 min at 70°C, followed by 30 min at 42°C.
4. Briefly microcentrifuge down any condensation that forms.
Extend DNA
5. To the primer/RNA mix add:
3 µL 25 mM 4dNTP mix
2 µL 0.1 M DTT
6 µL 5× first strand buffer.
Total volume is now 29.5 µL.
6. Add 0.5 µL (100 U) Superscript II and mix.
7. Incubate 45 min at 42°C.
8. Add 3 µL of 3 M sodium acetate, and 90 µL of 100% ethanol. Precipitate on dry ice
and microcentrifuge 30 min at maximum speed (10,000 rpm), 4°C.
9. Remove supernatant, rinse pellet with 70% ethanol, and dry the pellet in a speedvac.
10. Resuspend in 6 µL FENXB solution for resolution on a 6% acrylamide sequencing
gel (APPENDIX 3B). Use dideoxynucleotide sequencing reactions as markers (e.g., CPMB
Unit 7.4A).
Typically a cDNA template, rather than an RNA template, is used for the sequencing
reactions, allowing them to be performed with a DNA-dependent DNA polymerase (e.g.,
Sequenase; United States Biochemical).
Current Protocols in Nucleic Acid Chemistry
6.1.15
Chemical and
Enzymatic Probes
for Nucleic Acid
Structure
REAGENTS AND SOLUTIONS
Use deionized water in all recipes and protocol steps. For common stock solutions, see APPENDIX 2A; for
suppliers, see SUPPLIERS APPENDIX.
Aniline acetate buffer, 1 M
10 µL of 99.5% aniline
93 µL H2O
6 µL glacial acetic acid
Make fresh
CAUTION: Aniline is highly toxic.
Carrier RNA, 1 g/L or 2 g/L
Carrier RNA can be unlabeled RNA of interest or total yeast tRNA. Extract yeast
tRNA with 25:24:1 (v/v/v) phenol/chloroform/isoamyl alcohol (APPENDIX 2A) and
ethanol precipitate to remove any protein contaminants. Store at –20°C.
Citrate/EDTA/urea (CEU) buffer
For 100 mL:
10.25 mL 0.1 M citric acid
14.75 mL 0.1 M sodium citrate (final 25 mM citrate)
0.2 mL 0.5 M EDTA (APPENDIX 2A; final 1 mM)
∼30 mL H2O
42.04 g urea (final 7 M)
Adjust to pH 4.7 to 5.0 with HCl
Stable indefinitely at –20°C
Citrate/urea (CU) buffer
For 100 mL:
10.25 mL 0.1 M citric acid
14.75 mL 0.1 M sodium citrate (final 25 mM citrate)
∼30 mL of H2O
60.06 g urea (10 M final)
Adjust to pH 4.7 to 5.0 with HCl
Stable indefinitely at –20°C
Ethylnitrosourea (ENU)/ethanol solution
Add N-nitroso-N-ethylurea (ENU) to 100 µL of 100% ethanol until solution is
saturated. Centrifuge to pellet insoluble reagent. Make fresh.
CAUTION: ENU is highly toxic and a suspected carcinogen. follow appropriate precautions
for handling, storage, and disposal.
FENXB solution
95% formamide, redistilled
20 mM EDTA (APPENDIX 2A)
2 mM NaOH
0.05% xylene cyanol
0.05% bromphenol blue
Stable indefinitely at –5 to –20°C
FEXS solution
95% formamide, redistilled
10 mM EDTA (APPENDIX 2A)
0.05% xylene cyanol
0.1% SDS
Stable indefinitely at –5 to –20°C
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First strand buffer, 5×
250 mM Tris⋅Cl , pH 8.3 (APPENDIX 2A)
375 mM KCl
15 mM MgCl2
Stable indefinitely at –20°C
Kinase buffer, 10×
700 mM Tris⋅Cl, pH 7.6 (APPENDIX 2A)
100 mM MgCl2
50 mM dithiothreitol (DTT)
Stable indefinitely at –20°C
Na2CO3/EDTA solution
For 1 mL: 
50 µL 1 M Na2CO3, pH 11.7 (final 50 mM)
2 µL 0.5 M EDTA (APPENDIX 2A; final 1 mM)
948 µL H2O
Stable indefinitely at –20°C
Stop mix
20 mM EDTA (APPENDIX 2A)
0.3 M NaCl
1 µg/µL glycogen
Stable indefinitely at –20°C
Water, RNase free
Test water source for contaminating nuclease activity by incubating labeled RNA
in water and buffers for intended reaction time. Ascertain integrity of sample by
electrophoresis. Often deionized and glass-distilled water will be free of nucleases.
However, if water and/or buffer reagents contain nuclease activity, treat with DEPC
to inactivate (APPENDIX 2A). 
Autoclaved solutions are sometimes allowed to stand at room temperature, with loose caps,
for several days to remove all DEPC. Trace DEPC can inhibit reverse transcriptase and
other enzymes.
COMMENTARY
Background Information
Sensitivity to chemical and enzymatic re-
agents can often be used to test hypotheses
regarding solution exposure and single-
stranded versus double-stranded character
along the folded RNA chain; however, the data
generated in these experiments is most effective
when used in reference to a secondary structure
model for the RNA generated by other ap-
proaches. Computer-based energy-minimiza-
tion algorithms have proven extremely useful
in predicting simple RNA structures or in pro-
viding multiple local folding possibilities in
larger RNAs (Zuker, 1989; Gautheret et al.,
1990; Major et al., 1991; Malhotra et al., 1993;
Walter et al., 1994; Gorodkin et al., 1997).
These folding algorithms suffer from several
severe limitations in predicting longer RNAs,
however, tending to miss long-distance inter-
actions and lacking sufficient predictions of
nonstandard interactions among nucleotides. In
some instances, the physiologically relevant
RNAs will also contain nucleoside modifica-
tions that are not necessarily known or taken
into account. Perhaps most importantly, the
functional form of the molecules might not be
the most stable folded form under the condi-
tions used to fold the RNA in vitro. It is possible
that manipulation of the folding conditions
might identify methods that drive the majority
of a purified RNA into an appropriate structure,
assuming that there is some method to deter-
mine what constitutes an appropriate structure.
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Manipulation of folding conditions for RNAs
synthesized in vitro will be discussed below.
Structural analysis of RNAs and ribonucleo-
proteins (RNPs) can be used to determine sec-
ondary structure, facilitate modeling of tertiary
structure, and identify RNA-protein contacts.
The source of the material to be probed will
often dictate which labeling and probing tech-
niques are necessary. Primer extension is the
preferred method for analysis of large or cellu-
larly derived RNAs. The native RNA or RNP
complex can be assayed without manipulations
that may disrupt the integrity of the sample.
Postmodification or cleavage products are as-
sayed by extension of labeled DNA oligomers
with reverse transcriptase. End labeling tech-
niques can also sometimes be successful. How-
ever, in vivo–derived RNAs often possess 5′
methyl cap structures preventing labeling at
that terminus, and one or both termini in the
native RNA can be recessed or obscured by
protein in RNP structures. Chemical or enzy-
matic synthesis of RNA permits incorporation
of labeling groups during synthesis, or if nec-
essary, labeling sites can be engineered in the
synthetic RNAs. Studies involving novel se-
quences, subregions of larger RNAs, or RNP
reconstitution experiments sometimes require
the use of synthetic RNA. Chemical and enzy-
matic synthesis of RNA also provides an op-
portunity to incorporate nucleosides modified
with fluorescent, antigenic, or crosslinking
groups during synthesis.
Critical Parameters
The first principle in RNA structure analysis
is to begin with an RNA properly folded into
its physiologically relevant structure. Synthetic
RNA may or may not be in its properly folded
state. Gentle purification techniques should re-
tain the in vivo conformation of cellularly de-
rived RNAs and RNPs. However, folding of
many RNAs in vivo is not readily reproduced
in vitro, in many instances because the RNAs
require association of proteins to assume physi-
ologically appropriate structures. In these cases
it might be necessary to either isolate the RNAs
from cells or to associate the appropriate pro-
teins in vitro in a manner that can be demon-
strated to cause the RNA to assume a functional
structure. The best insurance that the RNA or
RNP of interest is correctly folded is to test its
functional or enzymatic activity. Other folding
assays will be necessary if no functional assay
exists.
The number of folding isoforms of an RNA
sample can sometimes be determined using
native polyacrylamide gel electrophoresis.
RNAs with extensive self-complementarity
often form multimers, which can be detected
on the native gel. Heat denaturation can be used
to melt present structures. Cooling rate, RNA
concentration, and the presence of mono- and
divalent cations all affect the subsequent fold-
ing isoform populations. In general, a faster
cooling rate, the absence of cations, and low
RNA concentrations favor intramolecular fold-
ing. Likewise, slow cooling in high salt with
high RNA concentrations favors intermolecu-
lar folding and the formation of multimers.
It should be noted that the RNA might need
to adopt more than one structure to carry out its
function(s) in vivo. Driving all of the RNA
sample (or protein-RNA complex) into a single
form might reflect only one aspect of the func-
tional RNA structure.
Once the RNA is properly folded, the struc-
ture-probing experiments can begin. There are
four factors that are key to experiment repro-
ducibility. The first is a consistent reaction mix.
Make a batch of all ingredients minus the re-
agent, mix, then aliquot to the necessary num-
ber of tubes. Always make enough for the
desired number of reactions plus one. This will
ensure that the amount of each component,
especially radiolabeled RNA, is identical be-
tween reactions. The second factor is reaction
time. Many of the probing reactions are short
(e.g., 10 min) to minimize the effect of any
contaminating nuclease activity. The number of
reactions attempted at once should not compro-
mise strict adherence to the reaction time.
Longer reaction times may be used effectively,
but short times have been found to reduce
secondary or nonspecific activities. The third
factor is the use of unlabeled carrier RNA.
Carrier RNA provides a constant substrate con-
centration for the probing reagents. The con-
centration of radiolabeled RNA is much less
than the carrier and is negligible in most reac-
tions. Therefore, any changes in labeling effi-
ciency between RNA preparations will have
little effect. Lastly, it is necessary to titrate the
amount of reagent for each particular RNA of
interest so that ∼10% of the RNA is cleaved.
The likelihood of multiple cleavages per mole-
cule is thereby reduced. Typically, the concen-
tration of RNA is held constant and the amount
of reagent is titrated until the desired extent of
modification is achieved. If the RNA sample of
interest is extremely limited, reagents are
titrated using a different RNA with the identical
unlabeled carrier RNA and buffer conditions.
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The presence of excess carrier RNA facilitates
reproducibility of cleavage conditions.
Troubleshooting
Primer-extension analysis of probing reac-
tions can encounter several pitfalls. For exam-
ple, breakdown in the sample results in termi-
nation products not produced by the probing
reagents. Extension of unmodified, uncleaved
RNA should identify these sites and allow for
their subtraction from the probing data. How-
ever, extensive degradation or strong secondary
structure–induced terminations may obscure
cleavages or modifications at several nucleo-
tides of interest. Synthetic RNA sample integ-
rity can be improved by changing the original
purification strategy or by further purification
to ensure that a discrete population exists. RNA
samples in crude cellular fractions should be
prepared as rapidly as possible at 0° to 4°C and
stored frozen (−80°C) when not in use to mini-
mize degradation by endogenous nucleases. To
alleviate secondary structure–induced termina-
tions, the primer-extension reaction condi-
tions and/or the reverse transcriptase can be
changed. Superscript II has demonstrated an
ability to proceed quite well through secon-
dary structure, but other reverse transcrip-
tases, such as AMV and Retrotherm, may
function better on a particular RNA. The
heat-stable Retrotherm can also be used at
elevated temperatures to minimize RNA sec-
ondary structure.
Achieving an interpretable amount of modi-
fication or cleavage is another problem often
encountered. The desired modification or
cleavage goal is 10% of the total RNA, in the
realm of single-hit kinetics. This rule mini-
mizes the presence of products resulting from
multiple modifications or cleavages. Typically,
the concentration of reagent is adjusted until
the 10% goal is reached for a batch of RNA,
carrier RNA, and reagent. Single cleavages or
modifications per RNA molecule usually allow
for detection of all available targets within the
region of interest. However, a hyper-reactive
site may exist that prevents further primer ex-
tension or observation of end-labeled RNA
products larger than the hyper-reactive nucleo-
tide. In this scenario, a new primer complemen-
tary to the region 5′ of the RNA modification
will be needed, or in the case of end-labeled RNA,
labeling the opposite end will allow analysis of
the remaining RNA region of interest.
All of the probing reactions are purposefully
designed to have nearly identical buffer and salt
conditions. RNA structure can change consid-
erably based on the amount and nature of coun-
terions and pH. Consistency in reaction condi-
tions between different probing reagents helps
to ensure the same structure is being examined.
The buffers and pH are changed only when they
may interfere with the chemical nature of the
reagent. It should be noted that the maximal
activities of several reagents and most of the
nucleases occur under different conditions than
those listed, but all have been used successfully
as described. The standard salt conditions can
be altered as desired but consistency is impor-
tant. Also, formation of RNA tertiary structures
is often very dependent on the amount and type
of counter-ions present.
Uncharacteristic modifications or cleavages
from probing reagents are sometimes observed.
Interpretation of atypical activities should be
regarded with appropriate caution. For exam-
ple, reagents used outside their optimal reaction
conditions or the presence of contaminating
activities could be responsible. It is also possi-
ble to observe inconsistencies between re-
agents with the same targets. Thus, using two
reagents that should cleave or modify an un-
paired nucleotide might give the result that
the nucleotide is sensitive to one but not the
other. In all probability, the reagents are func-
tioning properly, but subtle differences in
substrate binding and recognition can favor
one over the other.
Anticipated Results
There are several cautionary notes that
should be considered when interpreting RNA
footprinting data. First, it should always be
remembered that both purified RNAs and
RNA-protein complexes can exist in multiple
isoforms, whether folded and bound in vitro or
isolated intact from cells. As far as possible, the
heterogeneity of RNA sample of interest should
be investigated and taken into account when
interpreting sensitivity. Second, sensitivity to
cleavage or modification reagents is far more
useful in showing solution exposure than “pro-
tection” from reagents. Inaccessibility of even
the same region of a base to an individual
enzyme or chemical can vary from reagent to
reagent, and can have a number of causes in-
cluding involvement in hydrogen bonding,
folding into the interior of the RNA where it is
less exposed to the solvent, inappropriate
chemical states, and direct blockage by inter-
acting proteins. Thus, if protection is observed
in a particular region when a protein is added,
the protection might result from either direct
coverage by the protein or indirect effects of
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the bound protein acting at a distance. It should
be reemphasized that even detailed footprinting
results are often consistent with multiple hypo-
thetical structures, and for any complex RNA it
is likely that additional, independent types of
evidence will be needed to sort out the possi-
bilities.
Results of structure-probing experiments
are useful to qualitatively model RNA struc-
ture. The more reagents employed, the more
descriptive the analysis. Suspected anomalous
modifications or cleavages by a single reagent
can therefore be subtracted. Modifica-
tion/cleavage products can be quantitated by
phosphorimager analysis and analyzed using a
computer (e.g., ImageQuant from Molecular
Dynamics; visual inspection of autoradiograms
is fine for qualitative analysis). The accessibil-
ity of an RNA target is directly proportional to
the modification/cleavage product band inten-
sity. End-labeled RNA or labeled primer-exten-
sion products have one label per product mole-
cule. However, it is not simple to interpret the
reason that one target is preferred over another.
Targets on the surface of a molecule are likely
to be more accessible than those buried within
the interior of a tertiary structure, although local
steric effects may have as much impact on
reagent reactivity as global structure. Data ob-
tained using multiple reagents will better un-
cover the true solution structure of a target, and
the trend of several reagents should be regarded
as the rule, rather than a single hit by one
reagent. One should also keep in mind that
solution structure is dynamic and that RNA
molecular motion is dependent on temperature
and ionic environment.
Time Considerations
The design of structure-probing experi-
ments is dictated by the stability of the RNA
sample of interest and the half-life of radiola-
beled material. Cellularly derived RNAs or
RNPs often contain contaminating nuclease
activities, and these can be considerable de-
pending on the purification scheme employed.
It is therefore imperative to preserve samples
frozen at −80°C and to use them immediately
upon thawing. Synthetic RNAs are often free
of contaminating nucleases, depending on the
handling and manipulations the sample has
received. The structure-probing reactions are
usually short (e.g., 10 min) to reduce the effects
of any contaminating activities. Control reac-
tions should identify extraneous cleavages, pro-
vided that the majority of the sample is not
degraded in the reaction interval. A time course
incubation of the RNA of interest in the desired
reaction buffer may prove beneficial in identi-
fying sample integrity versus incubation time.
Longer reaction times, allowing for more sam-
ples, might then be used.
Modified/cleaved RNA intended for primer-
extension analysis can be stored frozen at
−80°C while the radiolabeled DNA primer is
made. End-labeled RNA should be resolved by
electrophoresis promptly after modifica-
tion/cleavage reactions are complete. Note that
only 10% of the RNA sample should be modi-
fied/cleaved; therefore, the detectable radiola-
bel signal from the modified/cleaved products
will only be 10% of the sample’s specific activity.
Experiments should proceed readily to maximize
signal from a batch of radiolabeled RNA.
Once all reaction components are in hand,
setting up the probing reactions, incubating,
and terminating the reactions for a single re-
agent should take ∼1 to 3 hr. Primer extension
typically takes 2 to 3 hr, and gel electrophoresis
on standard sequencing (6%) polyacrylamide
gels requires 2 to 3 hr.
Literature Cited
England, T., Bruce, A., and Uhlenbeck, O. 1980.
Specific labeling of 3′ termini of RNA with T4
RNA ligase. Methods Enzymol. 65:65-74.
Gautheret, D., Major, F., and Cedergren, R. 1990.
Computer modeling and display of RNA secon-
dary and tertiary structures. Methods Enzymol.
183:318-330.
Gorodkin, J., Heyer, L., and Stormo, G. 1997. Find-
ing the most significant common sequence and
structure motifs in a set of RNA sequences. Nucl.
Acids Res. 25:3724-3732.
Knapp, G. 1989. Enzymatic approaches to probing
of RNA secondary and tertiary structure. Meth-
ods Enzymol. 180:192-212.
Krol, A. and Carbon, P. 1989. A guide for probing
native small nuclear RNA and ribonucleoprotein
structures. Methods Enzymol. 180:212-227.
Major, F., Turcotte, M., Gautheret, D., Lapalme, G.,
Fillion, E., and Cedergren, R. 1991. The combi-
nation of symbolic and numerical computation
for three-dimensional modeling of RNA. Sci-
ence 253:1255-1260.
Malhotra, A., Gabb, H., and Harvey, S. 1993. Mod-
eling large nucleic acids. Curr. Opin. Struct. Biol.
3:241-246.
Milligan, J.F. and Uhlenbeck, O.C. 1989. Synthesis
of small RNAs using T7 RNA polymerase.
Methods Enzymol. 180:51-62.
Peattie, D.A. and Gilbert, W. 1980. Chemical probes
for higher-order structure in RNA. Proc. Natl.
Acad. Sci. U.S.A. 77:4679-4682.
Current Protocols in Nucleic Acid Chemistry
6.1.20
Probing RNA
Structure with
Chemical
Reagents and
Enzymes
Walter, A.E., Turner, D.H., Kim, J., Lyttle, M.H.,
Muller, P., Matthews, D.H., and Zuker, M. 1994.
Coaxial stacking of helixes enhances binding of
oligoribonucleotides and improves predictions
of RNA folding. Proc. Natl. Acad. Sci. U.S.A.
91:9218-9222.
Zuker, M. 1989. On finding all suboptimal foldings
of an RNA molecule. Science 244:48-52.
Contributed by William A. Ziehler and
 David R. Engelke
University of Michigan
Ann Arbor, Michigan
Current Protocols in Nucleic Acid Chemistry
6.1.21
Chemical and
Enzymatic Probes
for Nucleic Acid
Structure
